Emergence of daptomycin-resistant Staphylococcus aureus during treatment

Hideharu Hagiya, Yuto Haruki, Taeko Uchida, Tomoko Wada, Sumiko Shiota, Tomoharu Ishida, Hiroko Ogawa, Tomoko Murase, Fumio Otsuka

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


A 68-year-old man with persistent bacteremia accompanying a large iliopsoas abscess, vertebral osteomyelitis, discitis and central venous port infection caused by methicillin-resistant Staphylococcus aureus (MRSA) was admitted to our hospital. During the course of treatment, the emergence of a daptomycin (DAP)-resistant MRSA strain was confirmed; the minimum inhibitory concentration was 1 to 2 μg/mL for vancomycin and more than 1 μg/mL for DAP. Although the bacterial cell wall was not significantly thickened, an increased positive surface charge and single-nucleotide polymorphism within mprF have been confirmed in DAPresistant strains. Still rare, but clinicians need to be cautious of the emergence of DAP-resistant MRSA during treatment.

Original languageEnglish
Pages (from-to)73-78
Number of pages6
JournalInternal Medicine
Issue number1
Publication statusPublished - Jan 1 2016


  • Bacterial surface charge
  • Cell wall thickness
  • Creeping
  • MprF
  • Single-nucleotide polymorphism (SNP)
  • Staphylococcus aureus bacteremia (SAB)

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Emergence of daptomycin-resistant Staphylococcus aureus during treatment'. Together they form a unique fingerprint.

Cite this